Literature DB >> 16461791

Regulation of acquired immunity by gamma delta T-cell/dendritic-cell interactions.

Niraj Shrestha1, James A Ida, A Steven Lubinski, Maria Pallin, Gilla Kaplan, Patrick A J Haslett.   

Abstract

In humans, innate immune recognition of mycobacteria, including Mycobacterium tuberculosis and Mycobacterium leprae, involves toll-like receptor-2 (TLR-2), expressed on immature dendritic cells (DCs), and the T-cell gammadelta receptor expressed by a subpopulation of T cells that utilize Vdelta2 (Vdelta2 T cells). To investigate modulatory relationships between these host-cell populations in a microbial context, in vitro experiments were performed with human DCs and Vdelta2 T cells stimulated with model TLR-2 ligands and phosphoantigens, respectively. We observed that TLR-2-stimulated DCs enhanced interferon-gamma (IFN-gamma) production by Vdelta2 T cells; conversely, activated Vdelta2 T cells enhanced TLR-2-induced DC maturation via soluble factors including IFN-gamma, which costimulated interleukin-12 (IL-12) p70 secretion by DCs. Exposure of DCs to activated Vdelta2 T cells was critical for Th1 T-cell priming when TLR-2 stimulation was limiting. These results suggest that Vdelta2 T cells may play an adjuvant role in priming protective antimycobacterial immunity when TLR-2 stimulation is lacking, as may occur if the infectious inoculum is small, or if the pathogen is an intrinsically weak activator of DCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16461791     DOI: 10.1196/annals.1358.011

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  13 in total

Review 1.  Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response.

Authors:  A Reschner; P Hubert; P Delvenne; J Boniver; N Jacobs
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

Review 2.  Modulation of γδ T cell responses by TLR ligands.

Authors:  Daniela Wesch; Christian Peters; Hans-Heinrich Oberg; Kathrin Pietschmann; Dieter Kabelitz
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

3.  Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies.

Authors:  Jianhua Zhou; Ning Kang; Lianxian Cui; Denian Ba; Wei He
Journal:  Cell Mol Immunol       Date:  2011-06-13       Impact factor: 11.530

4.  Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.

Authors:  Amudhan Maniar; Xiaoyu Zhang; Wei Lin; Brian R Gastman; C David Pauza; Scott E Strome; Andrei I Chapoval
Journal:  Blood       Date:  2010-06-02       Impact factor: 22.113

5.  Gamma interferon secretion by human Vgamma2Vdelta2 T cells after stimulation with antibody against the T-cell receptor plus the Toll-Like receptor 2 agonist Pam3Cys.

Authors:  Carl O Deetz; Andrew M Hebbeler; Nadia A Propp; Cristiana Cairo; Illia Tikhonov; C David Pauza
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

6.  Th1-Th2 polarisation and autophagy in the control of intracellular mycobacteria by macrophages.

Authors:  James Harris; Sharon S Master; Sergio A De Haro; Monica Delgado; Esteban A Roberts; Jayne C Hope; Joseph Keane; Vojo Deretic
Journal:  Vet Immunol Immunopathol       Date:  2008-10-17       Impact factor: 2.046

7.  Helicobacter pylori induces activation of human peripheral γδ+ T lymphocytes.

Authors:  Benedetta Romi; Elisabetta Soldaini; Laura Pancotto; Flora Castellino; Giuseppe Del Giudice; Francesca Schiavetti
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

8.  Comparative gamma delta T cell immunology: a focus on mycobacterial disease in cattle.

Authors:  Brandon L Plattner; Jesse M Hostetter
Journal:  Vet Med Int       Date:  2011-05-16

Review 9.  Insights into the Relationship between Toll Like Receptors and Gamma Delta T Cell Responses.

Authors:  Asif Amin Dar; Rushikesh Sudam Patil; Shubhada Vivek Chiplunkar
Journal:  Front Immunol       Date:  2014-07-31       Impact factor: 7.561

Review 10.  Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy.

Authors:  Heleen H Van Acker; Sébastien Anguille; Viggo F Van Tendeloo; Eva Lion
Journal:  Oncoimmunology       Date:  2015-04-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.